Embedded Files
The North America medical marijuana market is expected to grow from US$ 7,170.17 million in 2022 to US$ 20,760.41 million by 2028. It is estimated to register a CAGR of 19.4% from 2022 to 2028.
The increasing acceptance and regulatory approvals of medical marijuana products are significant drivers fueling the growth of the North America medical marijuana market. Researchers and companies are actively exploring the therapeutic potential of cannabis, with tetrahydrocannabinol (THC) being a key component in many medicinal applications.
For instance, the US Food and Drug Administration (FDA) has approved several THC-based drugs. Cesamet, containing the synthetic cannabinoid nabilone, is prescribed to manage chemotherapy-induced nausea and vomiting when other treatments prove ineffective. Marinol and Syndros, both containing synthetic 9-THC (dronabinol), are approved to stimulate appetite in patients with AIDS-related wasting syndrome. The pipeline for marijuana-based therapeutics is also active, with products like nabiximols (Sativex), already approved in Canada, being used to treat spasticity and neuropathic pain associated with multiple sclerosis. Nabiximols combines THC with cannabidiol (CBD). Furthermore, Canadian companies like CanaQuest Medical Corp are seeking approval for new THC-based products like Mentabinol under Canada's Cannabis Act. These increasing approvals from regulatory bodies like the FDA are a major catalyst for the medical marijuana market's expansion.
North America Medical Marijuana Market Overview
The North America medical marijuana market encompasses the US, Canada, and Mexico, with the US currently holding the largest market share. This growth is driven by several factors, including increasing research and collaborations focused on novel therapeutic applications of cannabis, growing public awareness regarding its medical benefits, and the presence of key industry players in the region. Additionally, the expanding aging population across North America is expected to further contribute to market growth.
North America Medical Marijuana Strategic Insights
Strategic insights for the North America medical marijuana market offer a data-driven analysis of the industry's current landscape, highlighting key trends, major players, and regional variations. These insights provide actionable recommendations that can help stakeholders differentiate themselves by identifying underserved market segments or developing unique value propositions. By leveraging data analytics, industry players can anticipate market shifts, whether they are investors, manufacturers, or other stakeholders. Adopting a future-oriented perspective is crucial for long-term success in this dynamic region, enabling stakeholders to proactively position themselves for market changes and make informed decisions that drive profitability and achieve their business objectives.
North America Medical Marijuana Regional Insights
The geographic scope of the North America medical marijuana market
defines the specific areas in which businesses operate and compete. Understanding local nuances, such as differing consumer preferences (for example, the demand for specific product formats or delivery methods), varying economic conditions, and diverse regulatory environments, is essential for tailoring market strategies. Businesses can expand their market reach by identifying underserved areas or adapting their product offerings to meet local demands. A focused market approach allows for more effective resource allocation, targeted marketing campaigns, and improved positioning against local competitors, ultimately fostering growth within those specific areas.
North America medical marijuana market Segments Covered
North America medical marijuana market By Product Type
Dried Form
Extract Form
North America medical marijuana market By Application
Pain Management
Tourette's
Alzheimer's Disease
Migraines
Depression and Anxiety
Multiple Sclerosis
Cancer
North America medical marijuana market By Distribution Channel
Retail Pharmacy
E-Commerce
North America medical marijuana market Regions and Countries Covered
North America
US
Canada
Mexico
North America medical marijuana market leaders and key company profiles
Aphria, Inc.
CanaQuest Medical Corporation
Canopy Growth Corporation
Emerald Health Therapeutics Inc.
GW Pharmaceuticals
MARICANN INC.
Organigram Holdings Inc.
Panaxia Pharmaceutical Industries Ltd.
Phoena Holdings Inc.
VIVO Cannabis Inc
Other Reports:
North America Gummy Supplements Market: https://penzu.com/p/8503c42ca09ae4f7
North America Radiation-Hardened Electronics Market: https://github.com/SuryakantGadekar/Business-Market-Insights/issues/26
North America mHealth Market: https://sites.google.com/view/n-mhealth-market/home
North America Synthetic Biology Market: https://business-news-insights.blogspot.com/2025/05/north-america-synthetic-biology-market.html
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
Page updated
Google Sites
Report abuse